Cytotoxic effects and in vitro reversal of multidrug resistance by therapeutic ultrasound in human hepatocarcinoma cell line (HepG2)

Ultrasonics

Volumn 48, Issue 4, 2008, Pages 297-302

  Shao, Ze Yong ^a   Zhai, Bao Jin ^a   Zhao, Chun Liang ^a   Hu, Kai ^a   Shen, Ding Ming ^a   Wu, Feng ^a  

^a Institute of Ultrasonic Engineering in Medicine   (China)

Author keywords

Cavitation; High intensity focused ultrasound; Multidrug resistance; Neoplasm; Therapeutic ultrasound

Indexed keywords

ACOUSTIC WAVES; CELL CULTURE; CHEMOTHERAPY; HEALTH; PHOTOACOUSTIC EFFECT; ULTRASONIC TRANSMISSION; ULTRASONICS;

CANCER CELLS; CELL LINES; CYTOTOXIC EFFECTS; HUMAN HEPATOCARCINOMA; HUMAN MALIGNANCIES; IN-VITRO; MULTIDRUG RESISTANCE (MDR); WILD-TYPE (WT);

CELLS;

CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; RHODAMINE; VINCRISTINE;

ARTICLE; DRUG RESISTANCE; FLOW CYTOMETRY; HUMAN; IN VITRO STUDY; LIVER CELL CARCINOMA; LIVER TUMOR; METHODOLOGY; MULTIDRUG RESISTANCE; TUMOR CELL LINE; ULTRASOUND THERAPY;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CISPLATIN; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; FLOW CYTOMETRY; FLUOROURACIL; HUMANS; LIVER NEOPLASMS; RHODAMINES; ULTRASONIC THERAPY; VINCRISTINE;

EID: 48149113771     PISSN: 0041624X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ultras.2007.11.004     Document Type: Article

References (26)

1. Thomas H., and Coley H.M. Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting P-glycoprotein. Cancer Control 10 (2003) 159-165
2. Perez-Tomas R. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. Curr. Med. Chem. 13 (2006) 1859-1876
3. Szakacs G., Paterson J.K., Ludwig J.A., Booth-Genthe C., and Gottesman M.M. Targeting multidrug resistance in cancer. Nat. Rev. Drug Discov. 5 (2006) 219-234
4. Gottesman M.M., Fojo T., and Bates S.E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer 2 (2002) 48-58
5. Ozben T. Mechanisms and strategies to overcome multiple drug resistance in cancer. FEBS Lett. 580 (2006) 2903-2909
6. Fojo T., and Bates S. Strategies for reversing drug resistance. Oncogene 22 (2003) 7512-7523
7. Chaussy C., Thuroff S., Rebillard X., and Gelet A. Technology insight: high-intensity focused ultrasound for urologic cancers. Nat. Clin. Pract. Urol. 2 (2005) 191-198
8. Kennedy J.E. High-intensity focused ultrasound in the treatment of solid tumours. Nat. Rev. Cancer 5 (2005) 321-327
9. Mitragotri S. Healing sound: the use of ultrasound in drug delivery and other therapeutic applications. Nat. Rev. Drug Discov. 4 (2005) 255-260
10. Pitt W.G., Husseini G.A., and Staples B.J. Ultrasonic drug delivery - a general review. Expert Opin. Drug Deliv. 1 (2004) 37-56
11. Newman C.M., and Bettinger T. Gene therapy progress and prospects: ultrasound for gene transfer. Gene Ther. 14 (2007) 465-475
12. ter Haar G. Therapeutic applications of ultrasound. Prog. Biophys. Mol. Biol. 93 (2007) 111-129
13. Rappoport N. Combined cancer therapy by micellar-encapsulated drug and ultrasound. Int. J. Pharm. 277 (2004) 155-162
14. Zhai B.J., Shao Z.Y., Zhao C.L., Hu K., and Wu F. Development and characterization of multidrug resistant human hepatocarcinoma cell line in nude mice. World J. Gastroenterol. 12 (2006) 6614-6619
15. Tennant J.R. Evaluation of the trypan blue technique for determination of cell viability. Transplantation 2 (1964) 685-694
16. Tsuruo T. Molecular cancer therapeutics: recent progress and targets in drug resistance. Intern. Med. 42 (2003) 237-243
17. Borowski E., Bontemps-Gracz M.M., and Piwkowska A. Strategies for overcoming ABC-transporters-mediated multidrug resistance (MDR) of tumor cells. Acta Biochim. Pol. 52 (2005) 609-627
18. Krishna R., and Mayer L.D. Multidrug resistance (MDR) in cancer Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur. J. Pharm. Sci. 11 (2000) 265-283
19. Liscovitch M., and Lavie Y. Cancer multidrug resistance: a review of recent drug discovery research. IDrugs 5 (2002) 349-355
20. Lage H. MDR1/P-glycoprotein (ABCB1) as target for RNA interference- mediated reversal of multidrug resistance. Curr. Drug Targets 7 (2006) 813-821
21. Senchenkov A., Litvak D.A., and Cabot M.C. Targeting ceramide metabolism - a strategy for overcoming drug resistance. J. Nat. Cancer Inst. 93 (2001) 347-357
22. Guzman H.R., McNamara A.J., Nguyen D.X., and Prausnitz M.R. Bioeffects caused by changes in acoustic cavitation bubble density and cell concentration: a unified explanation based on cell-to-bubble ratio and blast radius. Ultrasound Med. Biol. 29 (2003) 1211-1222
23. Miller D.L., and Quddus J. Sonoporation of monolayer cells by diagnostic ultrasound activation of contrast-agent gas bodies. Ultrasound Med. Biol. 26 (2000) 661-667
24. Wu J. Theoretical study on shear stress generated by microstreaming surrounding contrast agents attached to living cells. Ultrasound Med. Biol. 28 (2002) 125-129
25. Liu Y., Cho C.W., Yan X.D., Henthorn T.K., Lillehei K.O., Cobb W.N., and Ng K.Y. Ultrasound-induced hyperthermia increases cellular uptake and cytotoxicity of P-glycoprotein substrates in multi-drug resistant cells. Pharm. Res. 18 (2001) 1255-1261
26. Liu Y., Lillehei K., Cobb W.N., Christians U., and Ng K.Y. Overcoming MDR by ultrasound-induced hyperthermia and P-glycoprotein modulation. Biochem. Biophys. Res. Commun. 289 (2001) 62-68